Helen Anne D'Alessandro

TL;DR: In this paper, the authors report isolated unilateral axillary lymphadenopathy (i.e., no imaging findings outside of visible lymphadopathy), which is ipsilateral to recent (prior 6 weeks) vaccination, as benign with no further imaging indicated, with ultrasound if clinical concern persists 6 weeks after the final vaccination dose.

TL;DR: A human second reader or the use of a CAD system can increase the cancer detection rate, but it is found that there is no statistical difference between the two because of the small sample size.

TL;DR: Patients with triple-negative breast cancer had a significantly higher IBTR rate than patients with other receptor phenotypes when treated with 3D-APBI, and overall outcomes were excellent, particularly for patients with estrogen receptor-positive disease.

TL;DR: In this paper, a pragmatic management approach based on clinical presentation, vaccination delivery, and imaging findings is proposed for patients with axillary adenopathy identified on breast imaging after coronavirus disease (COVID-19) vaccination.

TL;DR: Hamartomas may appear as homogeneously dense, well‐circumscribed masses, varying in appearance from the classically described encapsulated mixed fatty‐fibroglandular mass, if there is radiologic‐pathologic concordance, further surgical excision is not warranted.